Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 77.61

+3.5%

Nov 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1365)	3/20/2006 1:56:53 PM
From: Jibacoa	Read Replies (1) of 3722

ANX Seems to have found support at the 4.15 level and has been forming a base at 4.25 <g> It has had some good upticks lately, but was not able to trade above its Feb.28 H of 4.73 (the H yesterday was 4.72 & the H so far today 4.66 <g>) It needs to close above 4.73 in order to test its Jan.30 H at 5.20 ( when it made a 52wks. H ) bigcharts.marketwatch.com It reported its 4thQ results last week and although the loss for the Q was $3.5M, its R&D expenses were $3M compared with $691Ks in 2004. For the full Yr. its R&D expenses were $8.7M compared with $2.7M in 2004 ANX closed the Yr. with $22.6M in cash, compared with $13M in 2004 (it had a private placement in July of $20M.<g> It is planning to start a PIII of its CoFactor for patients with metastatic Colorectal Ca, but will delay the start to the 2ndQ since it has requested the FDA some revisions on the protocol including an increase in the number of patients to 1200. Will see if the stock can get to the $7 level this year.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next